Statement of Fresenius Medical Care North America Regarding Centers for Medicare & Medicaid Services Request for Information
August 19 2016 - 7:07PM
Business Wire
In response to the Centers for Medicare & Medicaid Services’
(CMS) recent Request for Information, Fresenius Medical Care
North America issued the following statement:
"We welcome the opportunity to provide information in support of
CMS’ effort to maintain and enhance a sustainable and responsible
system for the benefit of patients. We do not operate the kind of
program that CMS highlighted in the Request for Information to
steer patients receiving Medicaid benefits into exchange
plans."
"Too many Americans with kidney failure are unable to obtain and
afford health coverage of their choice. With the assistance of
charities like the American Kidney Fund, those in need are able to
gain access to coverage that is readily available to most other
Americans, including coverage in exchange plans. We look forward to
working with CMS, insurers and the community to put in place any
reforms that are necessary to ensure that charities like the AKF
can continue their important work and avoid abuses that could
threaten the viability and sustainability of exchange plans."
About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier health care
company focused on providing the highest quality care to people
with renal and other chronic conditions. Through its
industry-leading network of dialysis facilities, outpatient cardiac
and vascular labs, and urgent care centers, as well as the
country’s largest practice of hospitalist and post-acute providers,
Fresenius Medical Care provides coordinated health care services at
pivotal care points for hundreds of thousands of chronically ill
customers throughout the continent. As the world’s largest fully
integrated renal company, it offers specialty pharmacy and
laboratory services, and manufactures and distributes the most
comprehensive line of dialysis equipment, disposable products, and
renal pharmaceuticals. For more information, visit the FMCNA
website at www.freseniusmedicalcare.us. For information about
patient services, visit www.freseniuskidneycare.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160819005736/en/
Media Contact:Fresenius Medical Care North AmericaRobert
Sepucha, 781-699-4028Cell:
781-472-9750robert.sepucha@fmc-na.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2024 to May 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From May 2023 to May 2024